3 min

What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer GRACEcast Lung Cancer Video

    • Science

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

  • Copyright 2013 GRACE - All Rights Reserved

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

3 min

  • Copyright 2013 GRACE - All Rights Reserved

Top Podcasts In Science

BBC Inside Science
BBC Inside Science
BBC Radio 4
Hidden Brain
Hidden Brain
Hidden Brain, Shankar Vedantam
NASA's Curious Universe
NASA's Curious Universe
National Aeronautics and Space Administration (NASA)
When Music Speaks
When Music Speaks
Laura McPherson
The Energy Podcast
The Energy Podcast
Shell
Radiolab
Radiolab
WNYC Studios

More by GRACEcast

GRACEcast Cancer 101 Video
GRACEcast Cancer 101 Video
cancerGRACE - H. Jack West, MD
GRACEcast Head and Neck Cancer Video NEW
GRACEcast Head and Neck Cancer Video NEW
cancerGRACE - H. Jack West, MD
GRACEcast Bladder Cancer Video
GRACEcast Bladder Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Cancer 101 Audio
GRACEcast Cancer 101 Audio
cancerGRACE - H. Jack West, MD
GRACEcast Kidney Cancer Video
GRACEcast Kidney Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Pancreatic Cancer Video
GRACEcast Pancreatic Cancer Video
cancerGRACE - H. Jack West, MD